Log in to save to my catalogue

Modulation of radiation-induced oral mucositis by thalidomide: Preclinical studies

Modulation of radiation-induced oral mucositis by thalidomide: Preclinical studies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1815371663

Modulation of radiation-induced oral mucositis by thalidomide: Preclinical studies

About this item

Full title

Modulation of radiation-induced oral mucositis by thalidomide: Preclinical studies

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Strahlentherapie und Onkologie, 2016-08, Vol.192 (8), p.561-568

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
Oral mucositis is a common, dose-limiting early side effect of radio(chemo)therapy for head-and-neck tumors. The epithelial radiation response is accompanied by changes in the inflammatory signaling cascades mediated by the transcription factor nuclear factor-kappa B (NF-κB). The present study was initiated to determine the effect of the...

Alternative Titles

Full title

Modulation of radiation-induced oral mucositis by thalidomide: Preclinical studies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1815371663

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1815371663

Other Identifiers

ISSN

0179-7158

E-ISSN

1439-099X

DOI

10.1007/s00066-016-0989-5

How to access this item